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Transcriptional regulation: SWItching circuitry
Paul A. Wade and Alan P. Wolffe
Proteins of the SWI/SNF family disrupt chromatin,
hydrolysing ATP in the process. How they do so is still
mysterious, but recent studies indicate that they can be
targeted to the nuclear infrastructure and to particular
genes, where they cooperate with other enzymes to
activate or repress transcription.
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Enzymes drive biological processes. Enzymatic activity
does not occur at random within a cell, but is partitioned
into particular nuclear or cytoplasmic compartments. This
targeting of enzymes provides an important element of
control: a set of enzymes might be colocalized so as to
channel a substrate more efficiently along a metabolic
pathway, or they might be sequestered in an inaccessible
and inactive location. Defining the biological functions of
an enzyme requires information, not only about what it
does mechanistically, but also about the structural context
in which it acts. These goals are now beginning to be
achieved for members of the large family of DNA-
dependent ATPases that are characterized by similarity to
the SWI2/SNF2 subunit of the yeast SWI/SNF chromatin
remodelling complex [1,2]. Recent experiments have con-
nected different SWI2/SNF2 family members to actin and
the nuclear matrix [3–5], as well as to specific gene
regulation pathways [6–8].
The SWI/SNF complex of the budding yeast Saccharomyces
cerevisiae is the prototypical chromatin remodelling
machine. It consists of twelve proteins, which together are
competent to alter the histone–DNA interactions in nucle-
osomes in a manner dependent on ATP hydrolysis [9].
Eleven of the SWI/SNF complex subunits have now been
characterized, with the latest progress being the identifica-
tion of two actin-related proteins, Arp7 and Arp9, as func-
tional components [3,5]. Deletion analysis has shown that
the Arp7 and Arp9 genes are essential for correct function-
ing of the yeast SWI/SNF complex in gene regulation.
The presence of actin-related proteins in the SWI/SNF
complex raises several interesting functional possibilities.
Actin itself is an ATPase with structural similarity to
members of the heat shock protein 70 (Hsp70) family of
chaperones. This connection suggests that Arp7 and Arp9
might mediate ATP-dependent conformational changes in
large protein complexes, such as the histone octamer [3].
Alternatively, Arp7 and Arp9 might connect SWI/SNF to
actin-binding proteins, cytoskeletal processes involving actin
or structural components of the nuclear infrastructure [5].
Mutational analysis of Arp7 and Arp9, however, has
suggested that ATP binding and hydrolysis are not impor-
tant for their function in the SWI/SNF complex. Instead,
mutations that affect the function of Arp7 and Arp9 were
found to occur at sites where they would be expected to
destabilize structural features of the protein, including
their actin folds [5]. Moreover, Arp7 and Arp9 show no
similarity to those parts of actin that interact with known
actin-binding proteins. Thus, neither ATP hydrolysis nor
interactions with conventional actin-binding proteins
appears to contribute to the functioning of Arp7 and Arp9.
Yeast genetics indicates that Arp7 and Arp9 are important,
but does not tell us why this should be so. Fortunately,
some insight into this has come from work on the homolo-
gous complexes in metazoans.
The Drosophila gene Brahma (Brm) encodes a protein
highly similar in sequence to SWI2/SNF2. Brahma is
required for the developmental control of several of the
homeotic genes that define segmental identity in the
Drosophila embryo. The Brahma protein is assembled into
a large complex that includes several other proteins that
are homologous to subunits of the yeast SWI/SNF
complex, including two actin-related proteins [10]. The
equivalent mammalian complex has a similar subunit com-
position (Figure 1), in which the protein encoded by
Brahma-related gene 1, BRG1, forms a complex with the
‘BRG1-associated factors’ BAF53 and BAF47 [4]. BAF53
is an actin-related protein and BAF47 is β actin itself [4]. 
Mammalian cell lines have been generated that are
deficient in BRG1, but that contain all other components
of the BRG1 complex. These cells have been used to
demonstrate that BRG1 is essential for the recruitment of
BAF53 and BAF47 into a functional complex. This associ-
ation also induces stable interaction of the BRG1 complex
with an insoluble nuclear infrastructure containing both
chromatin and nuclear matrix. This interaction was found
to be promoted by T-cell receptor signalling in lympho-
cyte cell lines, and by direct exposure of nuclei to phos-
phatidylinositol 4,5-bis-phosphate (PIP2) in vitro. 
There is considerable evidence that T-cell activation
alters the abundance and metabolism of phosphoinositol
lipids in the nucleus [4]. Phosphoinositols are known
regulators of actin-dependent functions, and the BRG1
complex can bind known PIP2-responsive actin-binding
regulatory proteins. Furthermore, the nucleosome-depen-
dent ATPase activity of the BRG1 complex is inhibited by
latrunculin B, an inhibitor of actin polymerization [4].
There are thus strong indications that nuclear PIP2 and
the enzymes of phosphoinositol lipid metabolism are part
of a signalling pathway that regulates the activity of the
BRG1 complex, acting via BAF53 and BAF47 and their
association with nuclear actin-binding proteins and/or the
nuclear matrix [4]. The nature and roles of the nuclear
actin-binding proteins that interact with the BRG1
complex, and the precise signals that modulate the con-
centrations of nuclear phosphoinositol lipids, are among
the important issues that remain to be resolved [4].
The recognition that the functioning of the BRG1
complex involves its regulated sequestration within the
nuclear infrastructure provides a new and important area
for future research, but it does not help directly with our
understanding of how the complex works — in particular,
how it regulates gene expression by remodelling chro-
matin at a specific targeted promoter. A general problem
in understanding SWI/SNF family proteins has been the
lack of proven mechanisms for targeting their activities to
known genes. Progress in this direction is being made and
a recent study [6] has identified a route by which the
BRG1 complex is directed to specific target sites on chro-
matin that depends on the ligand-responsive glucocorti-
coid receptor.
The BRG1 complex has been known for a while to
facilitate transcriptional activation by the ligand-bound glu-
cocorticoid receptor, but the mechanism of targeting has
been obscure. Fryer and Archer [6] found that recruitment
of the BRG1 complex to the glucocorticoid receptor in vivo
is dependent on the presence of ligand. The physical inter-
action between the receptor and the BRG1 complex was
eliminated by addition of an antiprogestin drug, which also
blocked chromatin remodelling and transcriptional activa-
tion directed by the glucocorticoid receptor on the target
gene, in this case the well-studied long terminal repeat pro-
moter of mouse mammary tumor virus (MMTV). 
As the interaction of the glucocorticoid receptor with other
coactivators, such as the acetyltransferases p300 and SRC1,
was unaffected by the antiprogestin drug, Fryer and
Archer [6] concluded that hormone-dependent transcrip-
tional activation requires the BRG1 complex to bind to the
glucocorticoid receptor and remodel the local chromatin.
Because all earlier work on the BRG1 complex involved
the non-targeted disruption of histone–DNA interactions,
often with a very large molar excess of BRG1, the new
results provide the first hard evidence that the BRG1
complex plays an essential role in the known ability of the
glucocorticoid receptor to target chromatin remodelling
(Figure 2). It is presently unclear whether specific compo-
nents of the BRG1 complex make direct contact with the
glucocorticoid receptor or if the association is indirect.
Additional evidence that SWI/SNF family members can be
recruited to particular sites on chromosomes, where they
exert their chromatin remodelling functions to regulate
gene expression, has come from studies of Drosophila
embryogenesis. As well as Brahma itself, a further member
of the SWI/SNF family has been found to contribute to
segment specification during Drosophila development. This
is d-Mi2 [7], which interacts with Hunchback, product of
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Figure 1
Comparison the SWI/SNF complexes from
yeast, flies and humans. Subunits that are
structurally related are highlighted by the
yellow rectangles. Known regulatory targets
and activities are indicated. Each column lists
the known subunits of a single, well-defined
complex. ‘Regulatory target’ refers to a known
SWI/SNF complex partner that is a
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one of the ‘gap’ class segmentation genes; Hunchback in
turn binds directly to the regulatory elements of homeotic
genes to repress their transcription. The Xenopus Mi-2
homolog has been shown to be part of a protein complex
with histone deacetylase activity [8], so the repression of
homeotic genes might involve histone deacetylation. This
evidence implicating a SWI/SNF protein in a gene repres-
sion pathway is significant, as a global analysis of gene
expression in yeast found that 203 genes are activated and
126 repressed as a result of a swi2 mutation [11]. A limited
set of genes are thus either activated or repressed by alter-
ations in the activity of a SWI/SNF protein, strong evi-
dence that targeted chromatin remodelling is involved in
both the activation and repression of transcription.
With the discovery that SWI/SNF complexes include
subunits related to cytoskeletal proteins, and the elucida-
tion of regulated interactions between these complexes
and specific chromatin components, there is hope that
these intriguing enzymes will soon be integrated into
specific signalling pathways. Genome sequencing has
revealed 17 members of the SWI/SNF family in the yeast
S. cerevisiae, and 21 in the nematode Caenorhabditis elegans
[12]. Many of these proteins will be components of
distinct regulatory complexes that might be involved in
gene activation or repression or both (depending on the
target gene). It is also undoubtedly true that SWI/SNF
proteins contribute to chromatin and chromosomal
dynamics associated with the many other nuclear events
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Figure 2
A model for how the glucocorticoid receptor
regulates transcription of the MMTV promoter
in chromatin by recruiting the BRG1 complex.
(a) Glucocorticoid binding leads to targeting of
the receptor to the MMTV promoter, initially in
an inactive chromatin context. (b) The activated
glucocorticoid receptor recruits the BRG1
complex to the MMTV promoter, leading to
remodelling of the adjacent chromatin.
(c) Basal transcriptional machinery is recruited
to the MMTV promoter in the remodelled


















that use DNA as a template. What the recent papers
clearly establish is that the enzymatic activities of
SWI/SNF family proteins can be applied in a very precise
manner in response to signalling pathways as diverse as
those dependent on phosphoinositols, steroid hormones or
the developmentally-regulated appearance of a transcrip-
tional repressor. The emerging picture is that the
SWI/SNF proteins act in specific architectural contexts
within the nuclear infrastructure [4], at least in some cases
as components of specific regulatory complexes that
contain sequence-specific DNA-binding proteins and
other coactivators [6] or corepressors [7,8]. The available
evidence suggests that when and where SWI/SNF pro-
teins exert their regulatory functions will be determined
in large part by their selective localisation within such
structures and complexes.
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